Correction to: Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis.

Jiang, Huihui; Xu, Aiqun; Xia, Wanli; Xia, Xingyuan; Li, Pulin; Zhang, Binbin; Zhu, Ke; Zhou, Sijing; Wang, Ran

Jiang, Huihui; Xu, Aiqun; Xia, Wanli; Xia, Xingyuan; Li, Pulin; Zhang, Binbin; Zhu, Ke; Zhou, Sijing; Wang, Ran.

Afiliação

Jiang H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Xu A; Department of General Medicine, Hefei Second People's Hospital, Hefei, 230001, China.
Xia W; Department of Thoracic Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Xia X; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Li P; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Zhang B; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Zhu K; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Zhou S; Hefei Third Clinical College of Anhui Medical University, Hefei, 230022, China. zhousijing@yeah.net.
Wang R; Hefei Prevention and Treatment Center for Occupational Diseases, Hefei, 230022, China. zhousijing@yeah.net.

Cancer Cell Int ; 21(1): 520, 2021 Oct 04.

Article em En | MEDLINE | ID: mdl-34607571

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Cancer Cell Int Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google